Increased incidence of haemolytic anaemia in COVID-19 pandemic time? A cross-sectional study
, 1, 1
Abstract
Introduction: After the global impact of the Coronavirus Disease 2019 (COVID-19) pandemic, which affects over 50 million individuals worldwide, the immune system has been reported hyperactivation and heightened autoantibody production. Post the COVID-19 pandemic, the diagnosis of hemolytic anemia has also exhibited a noteworthy escalation in emergency department admissions, capturing the attention of clinicians in this setting. Considering that autoimmune haemolytic anaemias are also classified under this group, the study investigated whether there was in fact a change in the incidence of haemolytic anaemia.
Material and methods: The study included retrospective data from 591 patients admitted to the emergency department and diagnosed with anemia between September 2020 and September 2023. A retrospective review of patient records covered both pre- and post-diagnosis periods. The collected data comprised demographic information, laboratory values, primary diagnoses, and clinical outcomes. The classification resulted in three distinct groups: Chronic Anemia (CA), Anemia Due to Blood Loss (BLA), and Hemolytic Anemia (HA).
Results: Between 2020 and 2023, the incidence of anemia notably decreased among patients in the CA group, whereas a significant increase in anemia incidence was observed among patients in the HA group over the same study period (p value < 0.05).
Conclusions: The study found that there was indeed an increase in the incidence of haemolytic anaemia. Howewer with this, further detailed studies are needed to determine whether the rise in the incidence of hemolytic anemia during the COVID-19 pandemic is attributable to autoimmune disease.
Keywords: incidence of anemiahemolytic anemiaCOVID-19autoimmune diseases
References
- McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009; 12(4): 444–454.
- Vieth JT, Lane DR. Anemia. Hematol Oncol Clin North Am. 2017; 31(6): 1045–1060.
- Janz TG, Johnson RL, Rubenstein SD. Anemia in the emergency department: evaluation and treatment. Emerg Med Pract. 2013; 15(11): 1–15.
- Hébert PC, Van der Linden P, Biro G, et al. Physiologic aspects of anemia. Crit Care Clin. 2004; 20(2): 187–212.
- Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002; 69(4): 258–271.
- Hill QA, Stamps R, Massey E, et al. British Society for Haematology. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017; 176(3): 395–411.
- Drews RE. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med. 2003; 24(4): 607–622.
- Gupta S, Ahern K, Nakhl F, et al. Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv Hematol. 2011; 2011: 389854.
- Smith DL. Anemia in the elderly.Am Fam Physician. 2000 Oct 1. ; 62(7): 1565–72.
- Horowitz KM, Ingardia CJ, Borgida AF. Clin Lab Med. 2013 Jun. ; 33(2): 281–91.
- Irwin JJ, Kirchner JT. Anemia in children.Am Fam Physician. 2001 Oct 15. ; 64(8): 1379–86.
- Janus J, Moerschel SK. Evaluation of anemia in children.Am Fam Physician. 2010 Jun 15. ; 81(12): 1462–71.
- Papa L, Maguire L, Thundiyil JG, et al. Age and sex differences in blood product transfusions and mortality in trauma patients at a level I trauma center. Heliyon. 2023; 9(8): e18890.
- Dicker RC, Greenspan JR, Strauss LT, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization. Am J Obstet Gynecol. 1982; 144(7): 841–848.
- Noronha SA. Acquired and Congenital Hemolytic Anemia. Pediatr Rev. 2016; 37(6): 235–246.
- Scheckel CJ, Go RS. Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis. Hematol Oncol Clin North Am. 2022; 36(2): 315–324.
- Argüello Marina M, López Rubio M, Castilla García L. Autoimmune haemolytic anaemia. Med Clin (Barc). 2023; 160(1): 30–38.
- Marín JS, Mazenett-Granados EA, Salazar-Uribe JC, et al. Increased incidence of rheumatoid arthritis after COVID-19. Autoimmun Rev. 2023; 22(10): 103409.
- Sharma C, Bayry J. High risk of autoimmune diseases after COVID-19. Nat Rev Rheumatol. 2023; 19(7): 399–400.
- Al Khoufi E, Al-Muhainy B, Algadeeb K, et al. Autoimmune Hemolytic Anemia: A Late Presentation of Post-COVID-19 Syndrome. Oman Med J. 2023; 38(1): e467.
- Siegenthaler AG, Ghelani G, Brady A, et al. Hematologic Abnormalities After COVID-19 Infection: A Case of Coombs-Negative Hemolytic Anemia and Thrombocytopenia. J Investig Med High Impact Case Rep. 2023; 11: 23247096231207687.